Market research

Blood Storage & transportation Equipment

Explore licenses

360iResearch introduction

Blood Storage and Transportation Equipment: Executive Summary

Blood storage and transportation equipment supports the safe collection, preservation, handling, and delivery of whole blood, components, and related biological materials. The market includes temperature-controlled refrigerators, freezers, transport containers, monitoring systems, and associated handling equipment. Demand is shaped by transfusion-service requirements, expanding healthcare access, stricter traceability expectations, emergency preparedness, and the need to reduce temperature excursions and product wastage.

Inside the research

Coverage at a glance

Selected branches from the published table of contents. Follow a chapter to explore its complete hierarchy.

  1. Chapter 7 Equipment

    • Storage Units
    • Transportation Containers
    View chapter
  2. Chapter 8 Mode

    • Active
    • Passive
    View chapter
  3. Chapter 9 End User

    • Blood Banks
    • Diagnostic Laboratories
    • Hospitals
    • Mobile Collection Units
    More in this chapter

Operational Shifts Are Raising Requirements for Blood Logistics

Blood systems are moving from isolated storage practices toward connected, end-to-end cold-chain management. Hospitals, blood centers, laboratories, and emergency services increasingly require validated temperature control, continuous monitoring, documented custody, and rapid response to deviations. Decentralized care, mobile collection, disaster planning, and cross-facility transfers are also increasing the importance of portable equipment, reliable power, ergonomic handling, and standardized operating procedures. Regulatory attention to quality systems and traceability is encouraging replacement of informal processes with documented workflows and calibrated monitoring.

Artificial Intelligence Improves Visibility, Prediction, and Compliance

Artificial intelligence can strengthen blood-storage operations by analyzing sensor data, identifying abnormal temperature patterns, predicting equipment maintenance needs, and supporting inventory rotation. Machine-learning tools may also help match demand with available components, reduce avoidable expiry, and prioritize replenishment or redistribution. Their value depends on accurate data, interoperable systems, cybersecurity, human oversight, and validation against clinical and regulatory requirements. AI should therefore augment trained personnel rather than replace quality assurance, release decisions, or emergency protocols.

Regional Insights: Uneven Infrastructure Creates Distinct Equipment Priorities

North America emphasizes automation, compliance documentation, resilient emergency logistics, and integration with hospital information systems. Europe prioritizes harmonized quality procedures, energy efficiency, traceability, and cross-border consistency, while the Middle East is focused on dependable centralized infrastructure, high-capacity facilities, and temperature control in challenging climates. Africa faces greater variability in power reliability, transport distances, and rural access, increasing the value of robust, energy-efficient, and serviceable equipment. Latin America requires solutions that address uneven healthcare capacity, regional distribution, and transport reliability. Asia-Pacific combines advanced, highly automated systems in leading healthcare markets with substantial needs for scalable infrastructure, last-mile logistics, and dependable monitoring in developing settings.

Group Insights: Trade and Security Networks Shape Procurement Needs

ASEAN members generally require adaptable solutions that support varied regulatory environments, humid climates, island and cross-border logistics, and uneven cold-chain maturity. BRICS economies place emphasis on domestic production capability, large and diverse healthcare networks, and scalable infrastructure. The European Union benefits from common regulatory principles and coordinated quality expectations, although implementation remains nationally organized. G7 systems typically prioritize advanced monitoring, interoperability, sustainability, and resilience. GCC markets emphasize centralized healthcare capacity, high ambient-temperature performance, and dependable logistics. NATO members increasingly view medical cold-chain resilience, continuity planning, and interoperable emergency support as elements of broader health and security preparedness.

Country Insights: National Health Systems Define Equipment Priorities

Australia requires durable equipment and long-distance transport solutions for geographically dispersed services. Brazil and Mexico face varied infrastructure and distribution conditions, making monitoring, power resilience, and regional service capability important. Canada and the United States emphasize validated systems, traceability, emergency preparedness, and integration across large healthcare networks. China and India require scalable capacity alongside modernization and broader access. Japan and South Korea focus on precision, automation, reliability, and aging-population needs. France, Germany, Italy, Spain, and the United Kingdom prioritize regulated quality systems, energy efficiency, interoperability, and continuity of supply. Russia places importance on domestic resilience, geographic coverage, and dependable operation across challenging logistics environments.

Actionable Priorities for Leaders in Blood Cold-Chain Operations

Industry leaders should first map temperature-sensitive workflows from collection through final use, then identify excursion, power, transport, and data-integrity risks. Equipment specifications should emphasize validated performance, alarm management, calibration, backup power, serviceability, and compatibility with existing information systems. Organizations should pair procurement with staff training, preventive maintenance, documented contingency procedures, and routine review of wastage and excursion records. Suppliers and healthcare operators should also design for local climate and infrastructure conditions, protect connected systems against cyber threats, and use AI only where governance, explainability, validation, and human accountability are established.

Research Methodology for the Executive Assessment

This assessment uses a structured review of publicly available regulatory guidance, standards, healthcare-system documentation, technical literature, and institutional information relevant to blood storage and transportation. Findings were organized around equipment functions, cold-chain risks, digital monitoring, infrastructure conditions, and regional health-system characteristics. Comparative interpretation considered the required regional, country, and economic or security groupings. The analysis is qualitative and deliberately excludes market estimates, market sizing, market shares, forecasts, and company-specific claims.

Conclusion: Resilient, Connected Equipment Is Becoming Essential

Blood storage and transportation equipment is becoming a core component of safe, traceable, and resilient transfusion systems. The strongest operational priorities are validated temperature control, continuous visibility, dependable power, efficient transport, maintainable hardware, and disciplined quality management. Regional infrastructure differences require locally appropriate designs, while AI and digital integration can improve prediction and accountability when deployed under robust governance. Leaders that connect equipment decisions with workforce capability, emergency planning, cybersecurity, and end-to-end process control will be better positioned to protect blood quality and reduce preventable loss.

Research report

Table of contents

  1. 1.Preface
    1. 1.1Objectives of the Study
    2. 1.2Market Definition
    3. 1.3Market Segmentation & Coverage
    4. 1.4Years Considered for the Study
    5. 1.5Currency Considered for the Study
    6. 1.6Language Considered for the Study
    7. 1.7Key Stakeholders
  2. 2.Research Methodology
    1. 2.1Introduction
    2. 2.2Research Design
      1. 2.2.1Primary Research
      2. 2.2.2Secondary Research
    3. 2.3Research Framework
      1. 2.3.1Qualitative Analysis
      2. 2.3.2Quantitative Analysis
    4. 2.4Market Size Estimation
      1. 2.4.1Top-Down Approach
      2. 2.4.2Bottom-Up Approach
    5. 2.5Data Triangulation
    6. 2.6Research Outcomes
    7. 2.7Research Assumptions
    8. 2.8Research Limitations
  3. 3.Executive Summary
    1. 3.1Introduction
    2. 3.2CXO Perspective
    3. 3.3New Revenue Opportunities
    4. 3.4Next-Generation Business Models
    5. 3.5Industry Roadmap
  4. 4.Market Overview
    1. 4.1Introduction
    2. 4.2Industry Ecosystem & Value Chain Analysis
      1. 4.2.1Supply-Side Analysis
      2. 4.2.2Demand-Side Analysis
      3. 4.2.3Stakeholder Analysis
    3. 4.3Market Dynamics
      1. 4.3.1Key Drivers
      2. 4.3.2Key Restraints
      3. 4.3.3Key Opportunities
      4. 4.3.4Key Challenges
    4. 4.4Porter’s Five Forces Analysis
    5. 4.5PESTLE Analysis
    6. 4.6Market Outlook
      1. 4.6.1Near-Term Market Outlook (0–2 Years)
      2. 4.6.2Medium-Term Market Outlook (3–5 Years)
      3. 4.6.3Long-Term Market Outlook (5–10 Years)
    7. 4.7Go-to-Market Strategy
  5. 5.Market Insights
    1. 5.1Consumer Insights & End-User Perspective
    2. 5.2Consumer Experience Benchmarking
    3. 5.3Opportunity Mapping
    4. 5.4Distribution Channel Analysis
    5. 5.5Pricing Trend Analysis
    6. 5.6Regulatory Compliance & Standards Framework
    7. 5.7ESG & Sustainability Analysis
    8. 5.8Disruption & Risk Scenarios
    9. 5.9Return on Investment & Cost-Benefit Analysis
  6. 6.Cumulative Impact of Artificial Intelligence 2026
  7. 7.Blood Storage & transportation Equipment Market, by Equipment
    1. 7.1Introduction
    2. 7.2Storage Units
      1. 7.2.1Cryogenic Units
      2. 7.2.2Freezers
      3. 7.2.3Refrigerators
    3. 7.3Transportation Containers
      1. 7.3.1Active Containers
        1. 7.3.1.1Battery Powered
        2. 7.3.1.2Electrically Powered
      2. 7.3.2Passive Containers
        1. 7.3.2.1Dry Ice
        2. 7.3.2.2Gel Packs
        3. 7.3.2.3Phase Change Materials
  8. 8.Blood Storage & transportation Equipment Market, by Mode
    1. 8.1Introduction
    2. 8.2Active
    3. 8.3Passive
  9. 9.Blood Storage & transportation Equipment Market, by End User
    1. 9.1Introduction
    2. 9.2Blood Banks
    3. 9.3Diagnostic Laboratories
    4. 9.4Hospitals
    5. 9.5Mobile Collection Units
    6. 9.6Research Institutes
  10. 10.Blood Storage & transportation Equipment Market, by Distribution Channel
    1. 10.1Introduction
    2. 10.2Direct Sales
    3. 10.3Distributors
    4. 10.4Online Sales
  11. 11.Blood Storage & transportation Equipment Market, by Region
    1. 11.1Introduction
    2. 11.2Asia-Pacific
    3. 11.3North America
    4. 11.4Latin America
    5. 11.5Europe
    6. 11.6Middle East
    7. 11.7Africa
  12. 12.Blood Storage & transportation Equipment Market, by Group
    1. 12.1Introduction
    2. 12.2ASEAN
    3. 12.3GCC
    4. 12.4European Union
    5. 12.5BRICS
    6. 12.6G7
    7. 12.7NATO
  13. 13.Blood Storage & transportation Equipment Market, by Country
    1. 13.1Introduction
    2. 13.2United States
    3. 13.3Canada
    4. 13.4Mexico
    5. 13.5Brazil
    6. 13.6United Kingdom
    7. 13.7Germany
    8. 13.8France
    9. 13.9Russia
    10. 13.10Italy
    11. 13.11Spain
    12. 13.12China
    13. 13.13India
    14. 13.14Japan
    15. 13.15Australia
    16. 13.16South Korea
  14. 14.Competitive Landscape
    1. 14.1Market Share Analysis, 2025
    2. 14.2Market Concentration Analysis, 2025
      1. 14.2.1Concentration Ratio (CR)
      2. 14.2.2Herfindahl Hirschman Index (HHI)
    3. 14.3Recent Developments & Impact Analysis, 2025
    4. 14.4Product Portfolio Analysis, 2025
    5. 14.5Benchmarking Analysis, 2025
  15. 15.Company Profiles
    1. 15.1Arctiko ApS
    2. 15.2B Medical Systems S.à r.l.
    3. 15.3Binder GmbH
    4. 15.4Biobase Biodustry Co., Ltd.
    5. 15.5Esco Micro Pte Ltd
    6. 15.6Haier Biomedical Co., Ltd.
    7. 15.7Helmer Scientific Inc.
    8. 15.8PHC Corporation
    9. 15.9Scinics Co., Ltd.
    10. 15.10StemCyte Inc.
    11. 15.11Stirling Ultracold
    12. 15.12Terumo Corp.
    13. 15.13Thermo Fisher Scientific Inc.
    14. 15.14ThermoGenesis Holdings, Inc.
    15. 15.15Vita 34 AG
  16. 16.Key Experts

Loading the sample request form…